These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1323635)

  • 21. Effect of chronic renal failure on Na,K-ATPase alpha 1 and alpha 2 mRNA transcription in rat skeletal muscle.
    Bonilla S; Goecke IA; Bozzo S; Alvo M; Michea L; Marusic ET
    J Clin Invest; 1991 Dec; 88(6):2137-41. PubMed ID: 1661300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 5-hydroxytryptamine on sodium- and potassium-dependent adenosine triphosphatase and its reactivity toward ouabain.
    Stepp LR; Novakoski MA
    Arch Biochem Biophys; 1997 Jan; 337(1):43-53. PubMed ID: 8990266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
    Ozaki H; Nagase H; Urakawa N
    J Pharmacol Exp Ther; 1984 Oct; 231(1):153-8. PubMed ID: 6149301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous digitalis-like activity in mammalian brain.
    Fishman MC
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4661-3. PubMed ID: 228305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of supercritical fluid chromatography to characterize a labile digitalis-like factor.
    Graves SW; Markides KE; Hollenberg NK
    Hypertension; 2000 Dec; 36(6):1059-64. PubMed ID: 11116125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
    Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
    Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A non ouabain-like inhibitor of the sodium pump in uremic plasma ultrafiltrates and urine from healthy subjects.
    Gallice PM; Kovacic HN; Brunet PJ; Berland YF; Crevat AD
    Clin Chim Acta; 1998 May; 273(2):149-60. PubMed ID: 9657345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A labile sodium pump inhibitor from the peritoneal dialysate of hypertensive renal failure patients: estimates of potency.
    Graves SW; Tao QF; Markides KE; Williams GH; Hollenberg NK
    Clin Exp Hypertens; 1998; 20(5-6):611-6. PubMed ID: 9682917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin, fatty acids and sodium, potassium-ATPase inhibition by plasma factors during hemodialysis.
    Gault MH; Vasdev SC; Longerich L; Purchase L; Sampson C; Johnson E
    Nephron; 1992; 60(3):292-301. PubMed ID: 1314335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.
    Halperin JA; Riordan JF; Tosteson DC
    J Biol Chem; 1988 Jan; 263(2):646-51. PubMed ID: 2826458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral sodium transport inhibitor in acute volume expansion and low renin hypertension.
    Pamnani MB; Bryant HJ; Haddy FJ
    Hypertension; 1987 Nov; 10(5 Pt 2):I78-83. PubMed ID: 2824371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and properties of endogenous ouabain-like substances from hemofiltrate and adrenal glands.
    Schoner W; Heidrich-Lorsbach E; Kirch U; Ahlemeyer B; Sich B
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S29-31. PubMed ID: 7508021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of hemodialysis on the transport of sodium in erythrocytes from chronic renal failure patients maintained on hemodialysis.
    Gambhir KK; Parui R; Agarwal V; Cruz I
    Life Sci; 2002 Aug; 71(14):1615-21. PubMed ID: 12137908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat.
    Anderstam B; Mamoun AH; Södersten P; Bergström J
    J Am Soc Nephrol; 1996 Nov; 7(11):2453-60. PubMed ID: 8959639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Separation from uremic body fluids and normal urine of Na+, K+-ATPase inhibitor.
    Gallice P; Monti JP; Braguer D; Durand C; Manchon H; Murisasco A; Crevat A
    Adv Exp Med Biol; 1987; 223():215-8. PubMed ID: 2833847
    [No Abstract]   [Full Text] [Related]  

  • 37. [Endogenous ouabain-like substances in animal tissues].
    Lopina OD; Talaeva SIu; Stetsiuk NU; Kotlobaĭ AA; Boldyrev AA
    Ukr Biokhim Zh (1978); 1986; 58(6):74-84. PubMed ID: 3026074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells.
    Morgan K; Lewis MD; Spurlock G; Collins PA; Foord SM; Southgate K; Scanlon MF; Mir MA
    J Biol Chem; 1985 Nov; 260(25):13595-600. PubMed ID: 2997173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different cation transport inhibitor in malignant renal hypertension and in uraemia.
    Simon G
    Clin Sci (Lond); 1989 Mar; 76(3):329-33. PubMed ID: 2924525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A gas chromatographic-mass spectrometric analysis of organic acids in uremic ultrafiltrate (author's transl)].
    Maeda K; Niwa T; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):75-88. PubMed ID: 7289205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.